Core Viewpoint - Optima Health's partnership with Perkbox is strategically significant, enhancing distribution capabilities more than contributing directly to revenue growth [2][3]. Group 1: Contract Details - The annual contract with Perkbox is valued at £6.5 million and is part of an £8.3 million new business pipeline disclosed in Optima's December half-year results [3]. - This partnership provides Optima with direct access to Perkbox's corporate client base, which would have otherwise required extensive sales efforts to reach [3]. Group 2: Growth Strategy - Optima's growth strategy increasingly relies on securing large-scale contracts in both public and private sectors, as evidenced by the £290 million Armed Forces deal and the upcoming acquisition of People Asset Management (PAM) [4]. - The addition of an established employee benefits platform like Perkbox as a distribution partner enhances Optima's market reach without incurring significant costs [5]. Group 3: Valuation Context - Optima is currently trading at approximately 185p, which equates to about 6.8 times the forecast FY27 EV/EBITDA, compared to acquisition multiples in the sector ranging from 12 to 15 times [5]. - Despite a series of contract wins and being described as a profitable, cash-generative business with substantial acquisition capacity, the valuation discount has persisted [5]. Group 4: Future Outlook - While the recent deal may not immediately alter the valuation discount, it reinforces Optima's methodical approach to building scale in the market [6].